Seattle Genetics

Seattle Genetics

Bothell, WA, United States
Bothell United States
Employees:
890
Market Cap:
$7.82 billion
Revenue:
$418.08 million
5 Year Trend:
34.5%
Net Income:
$-161.14 million
NASDAQ:
SGEN
Industry:
Chemical Manufacturing

Seattle Genetics is a biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody-based therapies for the treatment of cancer. The company, headquartered in Bothell, Washington (a suburb of Seattle), is the industry leader in antibody-drug conjugates or ADCs, a technology designed to harness the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells. Wikipedia

Seattle Genetics
Bothell, WA, United States
Bothell United States
Employees:
890
Market Cap:
$7.82 billion
Revenue:
$418.08 million
5 Year Trend:
34.5%
Net Income:
$-161.14 million
NASDAQ:
SGEN
Industry:
Chemical Manufacturing

Seattle Genetics is a biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody-based therapies for the treatment of cancer. The company, headquartered in Bothell, Washington (a suburb of Seattle), is the industry leader in antibody-drug conjugates or ADCs, a technology designed to harness the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells. Wikipedia

9 jobs at Seattle Genetics

Jobs in